Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.

Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL.

Schizophr Res. 2007 Sep;95(1-3):134-42. Epub 2007 Jul 26.

2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
3.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
4.

Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL.

Psychopharmacology (Berl). 2008 Aug;199(3):331-88. doi: 10.1007/s00213-008-1072-4. Epub 2008 Jun 21. Review.

5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
7.

Human and animal studies of schizophrenia-related gating deficits.

Light GA, Braff DL.

Curr Psychiatry Rep. 1999 Oct;1(1):31-40. Review.

PMID:
11122903
8.

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy.

Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JE, Crippa JA, Abilio VC.

Front Pharmacol. 2016 Sep 9;7:303. doi: 10.3389/fphar.2016.00303. eCollection 2016. Review.

Supplemental Content

Support Center